Chenglong Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chenglong Huang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Jun Li
Department of Sports Medicine, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, CHINA
4 shared publications- Biao Cheng
Department of Sports Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publications Qiuchen Cai
Department of Sports Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publicationsWenyang Xia
Department of Sports Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publicationsZubin Zhou
Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China
2 shared publications- Biao Cheng
Department of Sports Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publication
Latest Publications
- 19 January 2026
- Published by IOP Publishing in Biomedical Materials
- Vol. 21 (1)
Dynamic stiffness drives BMSC chondrogenesis via Ihh-regulated H3K18 lactylation/Rcan1 axis and mitochondrial fission remodeling
Background: Cartilage defects pose significant clinical challenges due to limited regenerative capacity. Dynamic matrix stiffness, mimicking the physiological mechanical microenvironment, shows promise in directing stem cell chondrogenesis, but its molecular mechanisms remain unclear. Methods: Bone marrow mesenchymal stem cells (BMSCs) were cultured on engineered hydrogels with static soft (0.033 kPa), dynamic (0.031–0.126 kPa, time-dependent stiffening), and static stiff (0.126 kPa) conditions. We performed siRNA-mediated Ihh knockdown and Rcan1 overexpression, with chondrogenic differentiation assessed via COL2/SOX9 immunofluorescence. For molecular analyses, we conducted qPCR, CUT&Tag-PCR, Western blot, RNA-seq, H3K18la-targeted CUT&Tag sequencing, and transmission electron microscopy (TEM) for mitochondrial morphology assessment. Results: Dynamic stiffness significantly enhanced chondrogenic differentiation, as evidenced by immunofluorescence detection of elevated COL2 and SOX9 expression. Ihh mRNA expression levels were upregulated by dynamic stiffness. Transcriptome profiling analysis revealed that Ihh knockdown disrupted the expression of genes involved in the glycolytic pathway, while Western blot results showed that Ihh knockdown inhibited histone H3 lysine 18 lactylation (H3K18la). CUT&Tag sequencing revealed Ihh-dependent H3K18la enrichment at regulatory regions of mitochondria-associated genes, notably Rcan1. Ihh deficiency promoted mitochondrial fission, as evidenced by increased Drp1 and Fis1 mRNA expression levels and direct observation of enhanced mitochondrial fission via TEM. Crucially, Rcan1 overexpression rescued mitochondrial fusion, downregulated fission markers, and reinstated chondrogenic marker expression. Consistently, the LDHA inhibitor FX11 reduced lactate levels, diminished H3K18la, and downregulated Rcan1, confirming the metabolic dependence of this axis. RNA-seq analysis further established that Rcan1 overexpression reprogrammed signaling pathways critical for cell differentiation, including ECM-receptor interaction. Conclusion: Dynamic stiffness promotes BMSC chondrogenesis via the Ihh-H3K18la-Rcan1 axis, linking mechanical cues to epigenetic regulation of mitochondrial remodeling and providing a novel target for cartilage repair.
- 19 January 2026
- Published by IOP Publishing in Biomedical Materials
- Vol. 21 (1)
Dynamic stiffness drives BMSC chondrogenesis via Ihh-regulated H3K18 lactylation/Rcan1 axis and mitochondrial fission remodeling
Background: Cartilage defects pose significant clinical challenges due to limited regenerative capacity. Dynamic matrix stiffness, mimicking the physiological mechanical microenvironment, shows promise in directing stem cell chondrogenesis, but its molecular mechanisms remain unclear. Methods: Bone marrow mesenchymal stem cells (BMSCs) were cultured on engineered hydrogels with static soft (0.033 kPa), dynamic (0.031–0.126 kPa, time-dependent stiffening), and static stiff (0.126 kPa) conditions. We performed siRNA-mediated Ihh knockdown and Rcan1 overexpression, with chondrogenic differentiation assessed via COL2/SOX9 immunofluorescence. For molecular analyses, we conducted qPCR, CUT&Tag-PCR, Western blot, RNA-seq, H3K18la-targeted CUT&Tag sequencing, and transmission electron microscopy (TEM) for mitochondrial morphology assessment. Results: Dynamic stiffness significantly enhanced chondrogenic differentiation, as evidenced by immunofluorescence detection of elevated COL2 and SOX9 expression. Ihh mRNA expression levels were upregulated by dynamic stiffness. Transcriptome profiling analysis revealed that Ihh knockdown disrupted the expression of genes involved in the glycolytic pathway, while Western blot results showed that Ihh knockdown inhibited histone H3 lysine 18 lactylation (H3K18la). CUT&Tag sequencing revealed Ihh-dependent H3K18la enrichment at regulatory regions of mitochondria-associated genes, notably Rcan1. Ihh deficiency promoted mitochondrial fission, as evidenced by increased Drp1 and Fis1 mRNA expression levels and direct observation of enhanced mitochondrial fission via TEM. Crucially, Rcan1 overexpression rescued mitochondrial fusion, downregulated fission markers, and reinstated chondrogenic marker expression. Consistently, the LDHA inhibitor FX11 reduced lactate levels, diminished H3K18la, and downregulated Rcan1, confirming the metabolic dependence of this axis. RNA-seq analysis further established that Rcan1 overexpression reprogrammed signaling pathways critical for cell differentiation, including ECM-receptor interaction. Conclusion: Dynamic stiffness promotes BMSC chondrogenesis via the Ihh-H3K18la-Rcan1 axis, linking mechanical cues to epigenetic regulation of mitochondrial remodeling and providing a novel target for cartilage repair.
- Open Access
- 19 October 2024
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 112, 107100
Improve anti-biofilm efficacy of ultrasound by modulating the phase transition of exopolysaccharides
- 19 October 2024
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 112, 107100
Open AccessImprove anti-biofilm efficacy of ultrasound by modulating the phase transition of exopolysaccharides
- 10 September 2024
- Published by Elsevier in Carbohydrate Polymers
- Vol. 347, 122726
Exploring the antibiofilm potential of chitosan nanoparticles by functional modification with chloroquine and deoxyribonuclease
- 10 September 2024
- Published by Elsevier in Carbohydrate Polymers
- Vol. 347, 122726
Exploring the antibiofilm potential of chitosan nanoparticles by functional modification with chloroquine and deoxyribonuclease
- Open Access
- 10 July 2024
- Published by Wolters Kluwer Health in Journal of the Chinese Medical Association
- Vol. 87 (9) , 870-877
Course-based intra-articular injection of medical chitosan mitigates excessive deposition of triacylglycerides in the synovial tissue of the knee osteoarthritis
Background: This study aimed to investigate the clinical efficacy of intra-articular injections of medical chitosan for treating knee osteoarthritis (KOA) and measure the lipid metabolism profiles of the synovial tissue. Methods: Sixty patients with KOA undergoing conservative treatment were recruited and randomized into two groups: one without pharmacological intervention (OA group) and the other receiving course-based intra-articular medical chitosan injections (CSI group). Quantitative lipidomic profile of synovial tissue was analyzed. Functional scores, including Kellgren-Lawrence rating (K-L), Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scoring, and American Knee Society (AKS) scoring were conducted. Results: Survival from the initial conservative treatment to final knee arthroplasty was significantly longer in the CSI group compared to the OA group. Except for the presurgery VAS score, no statistically significant differences were observed in the other scores, including K-L, initial VAS, WOMAC, and AKS. However, the CSI group experienced more reductions in AKS-Knee subscores compared to the OA group. Compared to the CSI group, the OA group exhibited a significant upregulation in most differential lipids, particularly triacylglycerides (TAGs, 77%). The OA group had notably higher levels of long-chain unsaturated fatty acids. Conclusion: Intra-articular injection of medical chitosan significantly prolongs the survival period before knee arthroplasty and reduces the deposition of TAGs metabolites.
- 10 July 2024
- Published by Wolters Kluwer Health in Journal of the Chinese Medical Association
- Vol. 87 (9) , 870-877
Open AccessCourse-based intra-articular injection of medical chitosan mitigates excessive deposition of triacylglycerides in the synovial tissue of the knee osteoarthritis
Background: This study aimed to investigate the clinical efficacy of intra-articular injections of medical chitosan for treating knee osteoarthritis (KOA) and measure the lipid metabolism profiles of the synovial tissue. Methods: Sixty patients with KOA undergoing conservative treatment were recruited and randomized into two groups: one without pharmacological intervention (OA group) and the other receiving course-based intra-articular medical chitosan injections (CSI group). Quantitative lipidomic profile of synovial tissue was analyzed. Functional scores, including Kellgren-Lawrence rating (K-L), Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scoring, and American Knee Society (AKS) scoring were conducted. Results: Survival from the initial conservative treatment to final knee arthroplasty was significantly longer in the CSI group compared to the OA group. Except for the presurgery VAS score, no statistically significant differences were observed in the other scores, including K-L, initial VAS, WOMAC, and AKS. However, the CSI group experienced more reductions in AKS-Knee subscores compared to the OA group. Compared to the CSI group, the OA group exhibited a significant upregulation in most differential lipids, particularly triacylglycerides (TAGs, 77%). The OA group had notably higher levels of long-chain unsaturated fatty acids. Conclusion: Intra-articular injection of medical chitosan significantly prolongs the survival period before knee arthroplasty and reduces the deposition of TAGs metabolites.